References
- 1. Janisch NH, Gardner TB. Advances in Management of Acute Pancreatitis. Gastroenterology clinics of North America. 2016; 45(1): 1-8.
- 2. Zhang X, Zhu C, Wu D, Jiang X. Possible role of toll-like receptor 4 in acute pancreatitis. Pancreas. 2010; 39(6): 819-24.
- 3. Sah RP, Garg P, Saluja AK. Pathogenic mechanisms of acute pancreatitis. Current opinion in gastroenterology. 2012; 28(5): 507-15.
- 4. Lankisch PG, Apte M, Banks PA. Acute pancreatitis. Lancet (London, England). 2015; 386(9988): 85-96.
- 5. Gukovskaya AS, Gukovsky I, Algul H, Habtezion A. Autophagy, Inflammation, and Immune Dysfunction in the Pathogenesis of Pancreatitis. Gastroenterology. 2017; 153(5): 1212-26.
- 6. Bhatia M, Brady M, Shokuhi S, Christmas S, Neoptolemos JP, Slavin J. Inflammatory mediators in acute pancreatitis. The Journal of pathology. 2000; 190(2): 117-25.
- 7. Noreen M, Shah MA, Mall SM, Choudhary S, Hussain T, Ahmed I, et al. TLR4 polymorphisms and disease susceptibility. Inflammation research: official journal of the European Histamine Research Society [et al]. 2012; 61(3): 177-88.
- 8. Lucas K, Maes M. Role of the Toll Like receptor (TLR) radical cycle in chronic inflammation: possible treatments targeting the TLR4 pathway. Molecular neurobiology. 2013; 48(1): 190-204.
- 9. Lin YT, Verma A, Hodgkinson CP. Toll-like receptors and human disease: lessons from single nucleotide polymorphisms. Current genomics. 2012; 13(8): 633-45.
- 10. Beutler B. Innate immunity: an overview. Molecular immunology. 2004; 40(12): 845-59.
- 11. Frantz S, Kobzik L, Kim YD, Fukazawa R, Medzhitov R, Lee RT, et al. Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium. The Journal of clinical investigation. 1999; 104(3): 271-80.
- 12. Kielian T. Toll-like receptors in central nervous system glial inflammation and homeostasis. Journal of neuroscience research. 2006; 83(5): 711-30.
- 13. Sharif R, Dawra R, Wasiluk K, Phillips P, Dudeja V, Kurt-Jones E, et al. Impact of toll-like receptor 4 on the severity of acute pancreatitis and pancreatitis-associated lung injury in mice. Gut. 2009; 58(6): 813-9.
- 14. Li G, Wu X, Yang L, He Y, Liu Y, Jin X, et al. TLR4-mediated NF-kappaB signaling pathway mediates HMGB1-induced pancreatic injury in mice with severe acute pancreatitis. International journal of molecular medicine. 2016; 37(1): 99-107.
- 15. O'Neill LA, Golenbock D, Bowie AG. The history of Toll-like receptors - redefining innate immunity. Nature reviews Immunology. 2013; 13(6): 453-60.
- 16. Park BS, Lee JO. Recognition of lipopolysaccharide pattern by TLR4 complexes. Experimental & molecular medicine. 2013; 45: e66.
- 17. Rallabhandi P, Phillips RL, Boukhvalova MS, Pletneva LM, Shirey KA, Gioannini TL, et al. Respiratory syncytial virus fusion protein-induced toll-like receptor 4 (TLR4) signaling is inhibited by the TLR4 antagonists Rhodobacter sphaeroides lipopolysaccharide and eritoran (E5564) and requires direct interaction with MD-2. mBio. 2012; 3(4).
- 18. Rolland A, Jouvin-Marche E, Viret C, Faure M, Perron H, Marche PN. The envelope protein of a human endogenous retrovirus-W family activates innate immunity through CD14/TLR4 and promotes Th1-like responses. Journal of immunology (Baltimore, Md : 1950). 2006; 176(12): 7636-44.
- 19. Equils O, Lu D, Gatter M, Witkin SS, Bertolotto C, Arditi M, et al. Chlamydia heat shock protein 60 induces trophoblast apoptosis through TLR4. Journal of immunology (Baltimore, Md : 1950). 2006; 177(2): 1257-63.
- 20. Sun NK, Huang SL, Chang TC, Chao CC. TLR4 and NFkappaB signaling is critical for taxol resistance in ovarian carcinoma cells. Journal of cellular physiology. 2018; 233(3): 2489-501.
- 21. Burguillos MA, Svensson M, Schulte T, Boza-Serrano A, Garcia-Quintanilla A, Kavanagh E, et al. Microglia-Secreted Galectin-3 Acts as a Toll-like Receptor 4 Ligand and Contributes to Microglial Activation. Cell reports. 2015.
- 22. Schaefer L, Babelova A, Kiss E, Hausser HJ, Baliova M, Krzyzankova M, et al. The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages. The Journal of clinical investigation. 2005; 115(8): 2223-33.
- 23. Midwood K, Sacre S, Piccinini AM, Inglis J, Trebaul A, Chan E, et al. Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease. Nat Med. 2009; 15(7): 774-80.
- 24. Chiron D, Bekeredjian-Ding I, Pellat-Deceunynck C, Bataille R, Jego G. Toll-like receptors: lessons to learn from normal and malignant human B cells. Blood. 2008; 112(6): 2205-13.
- 25. Guillot L, Balloy V, McCormack FX, Golenbock DT, Chignard M, Si-Tahar M. Cutting edge: the immunostimulatory activity of the lung surfactant protein-A involves Toll-like receptor 4. Journal of immunology (Baltimore, Md : 1950). 2002; 168(12): 5989-92.
- 26. Biragyn A, Coscia M, Nagashima K, Sanford M, Young HA, Olkhanud P. Murine beta-defensin 2 promotes TLR-4/MyD88-mediated and NF-kappaB-dependent atypical death of APCs via activation of TNFR2. Journal of leukocyte biology. 2008; 83(4): 998-1008.
- 27. Croce K, Gao H, Wang Y, Mooroka T, Sakuma M, Shi C, et al. Myeloid-related protein-8/14 is critical for the biological response to vascular injury. Circulation. 2009; 120(5): 427-36.
- 28. Lehnardt S, Schott E, Trimbuch T, Laubisch D, Krueger C, Wulczyn G, et al. A vicious cycle involving release of heat shock protein 60 from injured cells and activation of toll-like receptor 4 mediates neurodegeneration in the CNS. The Journal of neuroscience: the official journal of the Society for Neuroscience. 2008; 28(10): 2320-31.
- 29. Dybdahl B, Wahba A, Lien E, Flo TH, Waage A, Qureshi N, et al. Inflammatory response after open heart surgery: release of heat-shock protein 70 and signaling through toll-like receptor-4. Circulation. 2002; 105(6): 685-90.
- 30. Wheeler DS, Chase MA, Senft AP, Poynter SE, Wong HR, Page K. Extracellular Hsp72, an endogenous DAMP, is released by virally infected airway epithelial cells and activates neutrophils via Toll-like receptor (TLR)-4. Respiratory research. 2009; 10: 31.
- 31. Roelofs MF, Boelens WC, Joosten LA, Abdollahi-Roodsaz S, Geurts J, Wunderink LU, et al. Identification of small heat shock protein B8 (HSP22) as a novel TLR4 ligand and potential involvement in the pathogenesis of rheumatoid arthritis. Journal of immunology (Baltimore, Md : 1950). 2006; 176(11): 7021-7.
- 32. Vabulas RM, Braedel S, Hilf N, Singh-Jasuja H, Herter S, Ahmad-Nejad P, et al. The endoplasmic reticulum-resident heat shock protein Gp96 activates dendritic cells via the Toll-like receptor 2/4 pathway. The Journal of biological chemistry. 2002; 277(23): 20847-53.
- 33. Okamura Y, Watari M, Jerud ES, Young DW, Ishizaka ST, Rose J, et al. The extra domain A of fibronectin activates Toll-like receptor 4. The Journal of biological chemistry. 2001; 276(13): 10229-33.
- 34. Smiley ST, King JA, Hancock WW. Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4. Journal of immunology (Baltimore, Md : 1950). 2001; 167(5): 2887-94.
- 35. Johnson GB, Brunn GJ, Kodaira Y, Platt JL. Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4. Journal of immunology (Baltimore, Md: 1950). 2002; 168(10): 5233-9.
- 36. Tang AH, Brunn GJ, Cascalho M, Platt JL. Pivotal advance: endogenous pathway to SIRS, sepsis, and related conditions. Journal of leukocyte biology. 2007; 82(2): 282-5.
- 37. Iwata Y, Yoshizaki A, Komura K, Shimizu K, Ogawa F, Hara T, et al. CD19, a response regulator of B lymphocytes, regulates wound healing through hyaluronan-induced TLR4 signaling. The American journal of pathology. 2009; 175(2): 649-60.
- 38. Liu-Bryan R, Scott P, Sydlaske A, Rose DM, Terkeltaub R. Innate immunity conferred by Toll-like receptors 2 and 4 and myeloid differentiation factor 88 expression is pivotal to monosodium urate monohydrate crystal-induced inflammation. Arthritis and rheumatism. 2005; 52(9): 2936-46.
- 39. Tarkowski A, Bjersing J, Shestakov A, Bokarewa MI. Resistin competes with lipopolysaccharide for binding to toll-like receptor 4. Journal of cellular and molecular medicine. 2010; 14(6b): 1419-31.
- 40. Xie H, Sheng L, Zhou H, Yan J. The role of TLR4 in pathophysiology of antiphospholipid syndrome-associated thrombosis and pregnancy morbidity. British journal of haematology. 2014; 164(2): 165-76.
- 41. Ando K, Hasegawa K, Shindo K, Furusawa T, Fujino T, Kikugawa K, et al. Human lactoferrin activates NF-kappaB through the Toll-like receptor 4 pathway while it interferes with the lipopolysaccharide-stimulated TLR4 signaling. The FEBS journal. 2010; 277(9): 2051-66.
- 42. Devaney JM, Greene CM, Taggart CC, Carroll TP, O'Neill SJ, McElvaney NG. Neutrophil elastase up-regulates interleukin-8 via toll-like receptor 4. FEBS letters. 2003; 544(1-3): 129-32.
- 43. Imai Y, Kuba K, Neely GG, Yaghubian-Malhami R, Perkmann T, van Loo G, et al. Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell. 2008; 133(2): 235-49.
- 44. Hirai K, Furusho H, Kawashima N, Xu S, de Beer MC, Battaglino R, et al. Serum Amyloid A Contributes to Chronic Apical Periodontitis via TLR2 and TLR4. Journal of dental research. 2019; 98(1): 117-25.
- 45. Perillo NL, Marcus ME, Baum LG. Galectins: versatile modulators of cell adhesion, cell proliferation, and cell death. Journal of molecular medicine (Berlin, Germany). 1998; 76(6): 402-12.
- 46. Radosavljevic G.D. PJ, Jovanovic I., Lukic M.L., Arsenijevic N. The two faces of galectin-3: roles in various pathological conditions. Ser J Exp Clin Res. 2016; 17(3): 187-98.
- 47. Henderson NC, Sethi T. The regulation of inflammation by galectin-3. Immunological reviews. 2009; 230(1): 160-71.
- 48. Dragomir AC, Sun R, Choi H, Laskin JD, Laskin DL. Role of galectin-3 in classical and alternative macrophage activation in the liver following acetaminophen intoxication. Journal of immunology (Baltimore, Md: 1950). 2012; 189(12): 5934-41.
- 49. Radosavljevic G, Jovanovic I, Majstorovic I, Mitrovic M, Lisnic VJ, Arsenijevic N, et al. Deletion of galectin-3 in the host attenuates metastasis of murine melanoma by modulating tumor adhesion and NK cell activity. Clinical & experimental metastasis. 2011; 28(5): 451-62.
- 50. Jiang HR, Al Rasebi Z, Mensah-Brown E, Shahin A, Xu D, Goodyear CS, et al. Galectin-3 deficiency reduces the severity of experimental autoimmune encephalomyelitis. Journal of immunology (Baltimore, Md: 1950). 2009; 182(2): 1167-73.
- 51. Volarevic V, Milovanovic M, Ljujic B, Pejnovic N, Arsenijevic N, Nilsson U, et al. Galectin-3 deficiency prevents concanavalin A-induced hepatitis in mice. Hepatology (Baltimore, Md). 2012; 55(6): 1954-64.
- 52. Mishra BB, Li Q, Steichen AL, Binstock BJ, Metzger DW, Teale JM, et al. Galectin-3 functions as an alarmin: pathogenic role for sepsis development in murine respiratory tularemia. PloS one. 2013; 8(3): e59616.
- 53. Li Y, Zhou ZG, Xia QJ, Zhang J, Li HG, Cao GQ, et al. Toll-like receptor 4 detected in exocrine pancreas and the change of expression in cerulein-induced pancreatitis. Pancreas. 2005; 30(4): 375-81.
- 54. Hall JC, Crawford HC. The conspiracy of autophagy, stress and inflammation in acute pancreatitis. Current opinion in gastroenterology. 2014; 30(5): 495-9.
- 55. Gu H, Werner J, Bergmann F, Whitcomb DC, Buchler MW, Fortunato F. Necro-inflammatory response of pancreatic acinar cells in the pathogenesis of acute alcoholic pancreatitis. Cell death & disease. 2013; 4: e816.
- 56. Jaffray C, Mendez C, Denham W, Carter G, Norman J. Specific pancreatic enzymes activate macrophages to produce tumor necrosis factor-alpha: role of nuclear factor kappa B and inhibitory kappa B proteins. Journal of gastrointestinal surgery: official journal of the Society for Surgery of the Alimentary Tract. 2000; 4(4): 370-7; discussion 7-8.
- 57. Jaffray C, Yang J, Carter G, Mendez C, Norman J. Pancreatic elastase activates pulmonary nuclear factor kappa B and inhibitory kappa B, mimicking pancreatitis-associated adult respiratory distress syndrome. Surgery. 2000; 128(2): 225-31.
- 58. Hietaranta A, Mustonen H, Puolakkainen P, Haapiainen R, Kemppainen E. Proinflammatory effects of pancreatic elastase are mediated through TLR4 and NF-kappaB. Biochemical and biophysical research communications. 2004; 323(1): 192-6.
- 59. Vaz J, Akbarshahi H, Andersson R. Controversial role of toll-like receptors in acute pancreatitis. World journal of gastroenterology. 2013; 19(5): 616-30.
- 60. Johnson GB, Brunn GJ, Platt JL. Cutting edge: an endogenous pathway to systemic inflammatory response syndrome (SIRS)-like reactions through Toll-like receptor 4. Journal of immunology (Baltimore, Md: 1950). 2004; 172(1): 20-4.
- 61. Chen X, Zhao HX, Bai C, Zhou XY. Blockade of high-mobility group box 1 attenuates intestinal mucosal barrier dysfunction in experimental acute pancreatitis. Scientific reports. 2017; 7(1): 6799.
- 62. Awla D, Abdulla A, Regner S, Thorlacius H. TLR4 but not TLR2 regulates inflammation and tissue damage in acute pancreatitis induced by retrograde infusion of taurocholate. Inflammation research: official journal of the European Histamine Research Society [et al]. 2011; 60(12): 1093-8.
- 63. Ding SQ, Li Y, Zhou ZG, Wang C, Zhan L, Zhou B. Toll-like receptor 4-mediated apoptosis of pancreatic cells in cerulein-induced acute pancreatitis in mice. Hepatobiliary & pancreatic diseases international: HBPD INT. 2010; 9(6): 645-50.
- 64. Cao Y, Adhikari S, Clement MV, Wallig M, Bhatia M. Induction of apoptosis by crambene protects mice against acute pancreatitis via anti-inflammatory pathways. The American journal of pathology. 2007; 170(5): 1521-34.
- 65. Sawa H, Ueda T, Takeyama Y, Yasuda T, Shinzeki M, Nakajima T, et al. Role of toll-like receptor 4 in the path-ophysiology of severe acute pancreatitis in mice. Surgery today. 2007; 37(10): 867-73.
- 66. Deng Y, Yang Z, Gao Y, Xu H, Zheng B, Jiang M, et al. Toll-like receptor 4 mediates acute lung injury induced by high mobility group box-1. PloS one. 2013; 8(5): e64375.
- 67. Pan LF, Yu L, Wang LM, He JT, Sun JL, Wang XB, et al. The toll-like receptor 4 antagonist transforming growth factor-beta-activated kinase (TAK)-242 attenuates taurocholate-induced oxidative stress through regulating mitochondrial function in mice pancreatic acinar cells. The Journal of surgical research. 2016; 206(2): 298-306.
- 68. Li HG, Zhou ZG, Li Y, Zheng XL, Lei S, Zhu L, et al. Alterations of Toll-like receptor 4 expression on peripheral blood monocytes during the early stage of human acute pancreatitis. Digestive diseases and sciences. 2007; 52(8): 1973-8.
- 69. Gao HK, Zhou ZG, Li Y, Chen YQ. Toll-like receptor 4 Asp299Gly polymorphism is associated with an increased risk of pancreatic necrotic infection in acute pancreatitis: a study in the Chinese population. Pancreas. 2007; 34(3): 295-8.
- 70. Zhang D, Zheng H, Zhou Y, Yu B, Li J. TLR and MBL gene polymorphisms in severe acute pancreatitis. Molecular diagnosis & therapy. 2008; 12(1): 45-50.
- 71. Hofner P, Balog A, Gyulai Z, Farkas G, Rakonczay Z, Takacs T, et al. Polymorphism in the IL-8 gene, but not in the TLR4 gene, increases the severity of acute pancreatitis. Pancreatology: official journal of the International Association of Pancreatology (IAP) [et al]. 2006; 6(6): 542-8.
- 72. Guenther A, Aghdassi A, Muddana V, Rau B, Schulz HU, Mayerle J, et al. Toll-like receptor 4 polymorphisms in German and US patients are not associated with occurrence or severity of acute pancreatitis. Gut. 2010; 59(8): 1154-5.
- 73. Arbour NC, Lorenz E, Schutte BC, Zabner J, Kline JN, Jones M, et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nature genetics. 2000; 25(2): 187-91.
- 74. Szabo G, Mandrekar P, Oak S, Mayerle J. Effect of ethanol on inflammatory responses. Implications for pancreatitis. Pancreatology: official journal of the International Association of Pancreatology (IAP) [et al]. 2007; 7(2-3): 115-23.
- 75. Chen GY, Nunez G. Sterile inflammation: sensing and reacting to damage. Nature reviews Immunology. 2010; 10(12): 826-37.
- 76. Amith SR, Jayanth P, Franchuk S, Finlay T, Seyrantepe V, Beyaert R, et al. Neu1 desialylation of sialyl alpha-2,3-linked beta-galactosyl residues of TOLL-like receptor 4 is essential for receptor activation and cellular signaling. Cellular signalling. 2010; 22(2): 314-24.
- 77. Zhou W, Chen X, Hu Q, Chen X, Chen Y, Huang L. Galectin-3 activates TLR4/NF-kappaB signaling to promote lung adenocarcinoma cell proliferation through activating lncRNA-NEAT1 expression. BMC cancer. 2018; 18(1): 580.
- 78. Cai G, Ma X, Chen B, Huang Y, Liu S, Yang H, et al. Galectin-3 induces ovarian cancer cell survival and chemoresistance via TLR4 signaling activation. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine. 2016; 37(9): 11883-91.
- 79. Nishikawa H, Suzuki H. Possible Role of Inflammation and Galectin-3 in Brain Injury after Subarachnoid Hemorrhage. Brain sciences. 2018; 8(2).
- 80. Stojanovic B, Jovanovic I, Stojanovic BS, Stojanovic MD, Gajovic N, Radosavljevic G, et al. Deletion of Galectin-3 attenuates acute pancreatitis in mice by affecting activation of innate inflammatory cells. European journal of immunology. 2019.
- 81. Pan LL, Deng YY, Wang R, Wu C, Li J, Niu W, et al. Lactose Induces Phenotypic and Functional Changes of Neutrophils and Macrophages to Alleviate Acute Pancreatitis in Mice. Frontiers in immunology. 2018; 9: 751.